Skip Nav Destination
1-20 of 140
Keywords: Peritoneal dialysisClose
Published Online: 04 October 2023
... dialysis per population and a weak negative correlation with the prevalence of reduced kidney function in the population aged 40–74 years. Conclusion: We found a large regional variation in the frequency of inpatient percutaneous kidney biopsies. Kidney transplants and peritoneal dialysis might be offered...
Sabrina Milan Manani, Maria Mattiotti, Matteo Marcello, Grazia Maria Virzì, Maddalena Gnappi, Davide Marturano, Ilaria Tantillo, Claudio Ronco, Monica Zanella
Nephron (2023) 147 (11): 665–672.
Published Online: 13 July 2023
... with iso-osmolar contrast media (CM). We report a case of contrast-induced encephalopathy (CIE) in a peritoneal dialysis (PD) patient, affected by diabetes, hypertension, and chronic heart failure. A 78-year-old PD patient (diuresis 1,000 mL) underwent a percutaneous angioplasty of the carotid. Immediately...
Savas Ozturk, Meltem Gursu, Mustafa Arici, Idris Sahin, Necmi Eren, Murvet Yilmaz, Sumeyra Koyuncu, Semahat Karahisar Sirali, Zeynep Ural, Belda Dursun, Enver Yuksel, Sami Uzun, Savaş Sipahi, Elbis Ahbap, Halil Yazici, Orcun Altunoren, Onur Tunca, Yavuz Ayar, Ebru Gok Oguz, Zulfukar Yilmaz, Serdar Kahvecioglu, Ebru Asicioglu, Aysegul Oruc, Rezzan Ataman, Zeki Aydin, Bulent Huddam, Murside Esra Dolarslan, Alper Azak, Serkan Bakırdogen, Ahmet Uğur Yalcin, Serhat Karadag, Memnune Sena Ulu, Ozkan Gungor, Elif Ari Bakir, Ali Rıza Odabas, Nurhan Seyahi, Alaattin Yildiz, Kenan Ates
Nephron (2023) 147 (5): 272–280.
Published Online: 02 May 2023
...: There are not enough data on the post-COVID-19 period for peritoneal dialysis (PD) patients affected from COVID-19. We aimed to compare the clinical and laboratory data of PD patients after COVID-19 with a control PD group. Methods: This study, supported by the Turkish Society of Nephrology, is a national...
Nephron (2023) 147 (2): 91–96.
Published Online: 21 March 2023
.... 2022 Diabetes Continuous glucose monitoring Hemodialysis Peritoneal dialysis Time in range Hemoglobin A1c (HbA1c) was first identified more than 50 years ago and correlated to the mean plasma glucose of the previous 3–4 months [ 1, 2 ]. For both the dialysis and the general population...
Ahmet Murt, Harika Oyku Dinc, Mehmet Riza Altiparmak, Serkan F. Yalin, Serap Yadigar, Ergun Parmaksiz, Bekir Kocazeybek, Meltem Pekpak, Muveddet Rezzan Ataman
Nephron (2022) 146 (6): 559–563.
Published Online: 20 May 2022
... disease patients. However, the persistence of immune responses in the long term is not known yet. This study aimed to evaluate humoral immune responses in peritoneal dialysis (PD) patients over 6 months and to analyze the effects of the booster dose. Methods: Humoral immune responses of PD patients were...
Tobias Bomholt, Bo Feldt-Rasmussen, Rizwan Butt, Rikke Borg, Mir Hassan Sarwary, Thomas Elung-Jensen, Thomas Almdal, Filip K. Knop, Kirsten Nørgaard, Ajenthen G. Ranjan, Anders Larsson, Marianne Rix, Mads Hornum
Nephron (2022) 146 (2): 146–152.
Published Online: 03 November 2021
... affect hemoglobin A 1c (HbA 1c ) levels in patients receiving peritoneal dialysis (PD). We compared HbA 1c with interstitial glucose measured by continuous glucose monitoring (CGM) in patients with type 2 diabetes receiving PD. Methods: Fourteen days of CGM (Ipro2, Medtronic) were performed in 23...
Anabela Malho Guedes, Roberto Marques, Ana Teresa Domingos, Ana Paula Silva, Idalécio Bernardo, Pedro Leão Neves, Anabela Rodrigues, Raymond T. Krediet
Nephron (2021) 145 (5): 474–480.
Published Online: 15 June 2021
... as a consequence. Hydrostatic convection is a major drive for microvascular protein transport, but most studies in peritoneal dialysis (PD) patients overlooked this mechanism. An association between peritoneal protein clearance (PPCl) and venous congestion has been reported recently. The aim of this study...
Tobias Bomholt, Thomas Idorn, Filip K. Knop, Morten B. Jørgensen, Ajenthen G. Ranjan, Marsela Resuli, Pernille M. Hansen, Rikke Borg, Frederik Persson, Bo Feldt-Rasmussen, Mads Hornum
Nephron (2021) 145 (1): 27–34.
Published Online: 26 October 2020
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Liraglutide Type 2 diabetes Chronic hemodialysis Diabetic nephropathy Peritoneal dialysis Diabetic kidney disease is the leading cause...
Nephron (2019) 141 (2): 112–118.
Published Online: 13 November 2018
...Chih-Wei Chiu; Tsung-Hsun Tsai; Cheng-Li Lin; Tzung-Hai Yen; I-Kuan Wang; Chi-Yuan Li Background/Aims: This study investigated whether peritoneal dialysis (PD) patients using icodextrin were at a reduced risk of stroke. Methods: From Taiwan National Health Insurance data, it was found...
Nephron (2017) 137 (3): 172–177.
Published Online: 28 July 2017
... to in the content or advertisements. End-stage renal disease Hemodialysis Peritoneal dialysis Morbid obesity Transplantation Dialysis dose Vascular access Obesity is an increasingly common health problem in most developed countries, particularly in the United States [ 1 ]. Obesity has grown...
Miguel Pérez Fontán, Mercè Borràs Sans, Maria Auxiliadora Bajo Rubio, Ana Rodriguez-Carmona, Angels Betriu, José Maria Valdivielso, Elvira Fernández, for the NEFRONA Study investigators
Nephron (2017) 136 (2): 111–120.
Published Online: 25 February 2017
... of this condition in patients undergoing peritoneal dialysis (PD) have been insufficiently investigated. Objectives and Method: Following a prospective, multicenter, observational design, we studied 237 patients who were treated with PD for ≥3 months, without any clinical background of cardiovascular (CV) disease...
Virginia Sánchez, Ramón Paniagua, Maria del Carmen Prado, Carmen Mora, Oscar Orihuela, Francisco Martínez-Baca, Estela Elizabeth Pérez, Claudia Calzada, Renata Romero, Marcela Avila
Nephron (2017) 135 (2): 120–128.
Published Online: 15 November 2016
... kidney disease; both are associated with all-cause and cardiovascular mortality. However, a link between them has not yet been established. The aim of this study was to analyze DD as a surrogate marker of fibrosis and its association with TH in incident patients on peritoneal dialysis (PD). Methods...
Giacomo Bovio, Ciro Esposito, Giovanni Montagna, Silvia Brazzo, Vittoria Esposito, Massimo Torreggiani, Luca Semeraro, Hellas Cena
Nephron (2016) 133 (4): 253–260.
Published Online: 09 July 2016
... in this population. The aim of this study was to assess nutrient intakes in hemodialysis (HD) and peritoneal dialysis (PD) patients. Methods: A clinical cross-sectional study was conducted over 7 days on 14 dialysis patients (98 days) who were trained to keep a weighed food record and a 7-day food diary. Nutrient...
Nephron (2015) 131 (3): 210–219.
Published Online: 04 November 2015
...Ying Lu; Luyan Gao; Lingyun Li; Ye Zhu; Zhi Wang; Huaying Shen; Kai Song Background/Aims: Peritoneal fibrosis is one of the long-term complications in peritoneal dialysis (PD) patients. Recent evidences have suggested that hydrogen sulfide (H 2 S) is beneficial in treating various fibrotic diseases...
Nephron (2015) 129 (3): 155–163.
Published Online: 06 March 2015
...Jialin Wang; Nan Zhu; Weijie Yuan Background: Glucose degradation products (GDPs) in peritoneal dialysis (PD) solution (PDS) have been shown to inflict damage to the kidney, which is the major organ for advanced glycosylation end product elimination. Hence, this study investigated whether new PDSs...
Philip K.T. Li, Marc Dorval, David W. Johnson, Peter Rutherford, Evgeny Shutov, Ken Story, Joanne M. Bargman
Nephron (2015) 129 (4): 233–240.
Published Online: 04 March 2015
...Philip K.T. Li; Marc Dorval; David W. Johnson; Peter Rutherford; Evgeny Shutov; Ken Story; Joanne M. Bargman Background/Aims: Poor glycemic control can lead to increased morbidity and mortality in peritoneal dialysis (PD) patients. Serum fructosamine may be a more reliable marker of glycemic...
Fabiane Rossi dos Santos Grincenkov, Natália Fernandes, Beatriz dos Santos Pereira, Kleyton Bastos, Antônio Alberto Lopes, Fredric O. Finkelstein, Roberto Pecoits-Filho, Abdul Rashid Qureshi, José Carolino Divino-Filho, Marcus Gomes Bastos
Nephron (2015) 129 (2): 97–103.
Published Online: 28 January 2015
... as the social and emotional aspects, as these parameters may be associated with clinical outcomes in end-stage renal disease patients. Aim: To evaluate the impact of self-determined HRQOL at admission on survival of incident peritoneal dialysis (PD) patients. Patients and Methods: A total of 1,624 incident...
Nephron (1996) 74 (3): 548–554.
Published Online: 24 December 2008
... undergoing continuous ambulatory peritoneal dialysis (CAPD). Nine clinically stable patients (1 male, 8 female; mean age 55.4 years; mean duration of CAPD 14.1 months) were studied. Twelve normal volunteers were studied as controls. GHRH and clonidine stimulation tests were performed prior to starting rhEPO...
Nephron (1996) 74 (1): 26–32.
Published Online: 24 December 2008
...H.F.H. Brulez; H.A.T. Dekker; P.L. Oe; D. Verbeelen; P.M. ter Wee; H.A. Verbrugh The biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid (AA-PDF) was compared to that of a 2.27% glucose-based peritoneal dialysis fluid (G-PDF). Peritoneal macrophages (PMO), isolated from...
Tor-Erik Widerøe, Ketil J. Dahl, Leif C. Smeby, Torveig Balstad, Sidsel Cruischank-Flakne, Ivar Følling, Ole Simondsen, Jarl Ahlmen, Størker Jørstad
Nephron (1996) 74 (2): 283.
Published Online: 24 December 2008
...Tor-Erik Widerøe; Ketil J. Dahl; Leif C. Smeby; Torveig Balstad; Sidsel Cruischank-Flakne; Ivar Følling; Ole Simondsen; Jarl Ahlmen; Størker Jørstad Seven type I insulin-dependent diabetic patients on continuous ambulatory peritoneal dialysis treatment were selected for this study. Each patient...